2025-05-22 06:01:36 pm | Source: reuters
India`s Sun Pharma posts quarterly profit rise on strong demand for rare disease drugs
Sun Pharmaceutical, India's largest drugmaker by revenue, reported a rise in adjusted quarterly profit on Thursday, driven by strong domestic demand for its drugs to treat rare diseases.
The Mumbai-based firm's consolidated profit before exceptional items and tax rose 24% to 36.16 billion rupees ($420.7 million) in the three months ended March 31.
Disclaimer:
The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references.
To Read Complete Disclaimer Click Here
Latest News
Geopolitical tensions, oil prices, inflation data to...
Company Update : Vodafone Idea Ltd By Motilal Oswal ...
Indian startups raise $184.75 million this week
FM Nirmala Sitharaman takes stock of financial inclu...
Buy Bajaj Finance Ltd For Target Rs. 10,225 By Axis ...
Karan Johar reflects on fatherhood journey, says bei...
Buy Hindware Ltd For Target Rs. 325 - Choice Broking...
Randeep Hooda reflects on his father`s support durin...
Life Insurance Sector Update : Ending the year on a...
Add Awfis Space Solutions Ltd For Target Rs. 750 - C...
